Searched for
VACCINE REGULATORY SYSTEM
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- BRICS+ agriculture beyond borders: Trade and resilience for a food-secure worldWith India’s leadership and BRICS+ cooperation, agriculture can become not only a source of food, but a foundation for resilience, prosperi...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Is Quad the Asian NATO or ocean foam? What Delhi meet revealsQuad foreign ministers met in Delhi focusing on practical cooperation. New initiatives target critical minerals, maritime surveillance, and...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- 11 countries already recognise Indian pharmacopoeia as their standard: DCGI Rajeev RaghuvanshiIndia is supplying drugs, vaccines, and medical devices to over 200 countries, with 11 countries recognizing Indian pharmacopoeia standards...
- India's top drug regulator meets WHO standards for functional vaccine regulatory systemA WHO-led team reviewed India's vaccine regulatory system from September 16 to 20. The system was declared functional by meeting WHO's glob...
- Serum Institute writes to Union Health Minister proposing reforms in drug regulatory systemThe letter stated that on the directions of the prime minister, a high-powered Inter-Ministerial Committee for reforming the drug regulator...
- Zydus vaccine under close review, approval likely to get delayedZydus had applied for emergency use authorisation (EUA) for its vaccine on July 1, but it is yet to be taken up by the subject expert commi...
- UK regulator to fast-track vaccine updates to combat new Covid variantsMHRA said this is because authorised COVID-19 vaccines that are modified in response to new variants will not need a brand new approval o...
- Serum Institute writes to PMO proposing reforms in drug regulatory systemIn the letter, Prakash Kumar Singh, the Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII) refe...
- India in touch with UK drug officials on Oxford Covid-19 vaccine: Vaccine Task Force Committee“India’s drug regulator is in touch with UK drug authorities on the approval progress of the AZ/Oxford vaccine trial,” Vinod Paul, head of ...
- India looking to be self-reliant in development, production of vaccine against COVID-19While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass ...
- High-level government panel suggests single-window system for new drug approvalsThe committee, set up by the cabinet secretary after Prime Minister Narendra Modi sought overhauling of the country’s drug regulatory syste...
- India's vaccine regulator National Regulatory Authority of India meets WHO standardsIndia's Rs 19,000-crore vaccine industry accounts for exports worth 13 billion US dollars to 150 countries.
- WHO moots parallel checks on Indian vaccinesThe World Health Organisation (WHO) has proposed a parallel review of vaccines manufactured by Indian companies, to be carried out by the C...
Load More
